Forbes-Tate
Forbes-Tate filed a Q1 report for National Association of Proton Therapy on April 14, 2025, reporting $60,000 in lobbying income.
Lobbying for National Association of Proton Therapy · Non-profit organization focused on access to Proton Therapy
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; issues related to S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; issues related to H.R. 2120 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; issues related to S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; issues related to H.R. 2120 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
Issues related to continued access to and provider reimbursement for proton beam therapy; issues related to the forthcoming Fiscal Year 2026 Labor-HHS appropriations process.
Issues pertaining to veterans' access to proton therapy.